We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
-0.77%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+640.53%
AUM
$7.55B
AUM Growth
-$472M
Cap. Flow
-$301M
Cap. Flow %
-3.99%
Top 10 Hldgs %
20.77%
Holding
863
New
59
Increased
344
Reduced
256
Closed
128

Top Buys

Rank Stock Value
1
NKE icon
Nike
NKE
+$25.4M
2
ABBV icon
AbbVie
ABBV
+$21.9M
3
KYNB
Kyntra Bio
KYNB
+$19.2M
4
WM icon
Waste Management
WM
+$19M
5
GILD icon
Gilead Sciences
GILD
+$17.7M

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$70.2M
2
ARRY
Array Biopharma Inc
ARRY
+$45.8M
3
BIIB icon
Biogen
BIIB
+$43.3M
4
META icon
Meta Platforms (Facebook)
META
+$24.8M
5
AMGN icon
Amgen
AMGN
+$21.7M

Sector Composition

Rank Sector Weight
1 Healthcare 31.81%
2 Technology 18.27%
3 Financials 10.05%
4 Consumer Discretionary 9.39%
5 Communication Services 7.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LEG icon
701
Leggett & Platt
LEG
$1.31B
$221K ﹤0.01%
+5,389
New +$211K
VRSN icon
702
VeriSign
VRSN
$26.6B
$208K ﹤0.01%
1,105
-8,253
-88% -$1.7M
UDR icon
703
UDR
UDR
$12.3B
$204K ﹤0.01%
4,199
+4,179
+20,895% +$197K
EMQQ icon
704
EMQQ The Emerging Markets Internet & Ecommerce ETF
EMQQ
$273M
$202K ﹤0.01%
6,460
– –
BMI icon
705
Badger Meter
BMI
$4.03B
$201K ﹤0.01%
3,746
-2,926
-44% -$158K
LTM
706
DELISTED
LATAM Airlines Group S.A American Depositary Shares (Each representing 1 Common Share)
LTM
$197K ﹤0.01%
17,722
+842
+5% +$7.75K
AMX icon
707
America Movil
AMX
$71.2B
$189K ﹤0.01%
12,736
+316
+3% +$4.53K
CIG icon
708
CEMIG Preferred Shares
CIG
$6.01B
$189K ﹤0.01%
109,139
-9,150
-8% -$16.9K
QCLS
709
Q/C Technologies Inc
QCLS
$22.9M
$174K ﹤0.01%
3
– –
OVV icon
710
Ovintiv
OVV
$16.4B
$121K ﹤0.01%
5,284
– –
CHMA
711
DELISTED
Chiasma, Inc. Common Stock
CHMA
$116K ﹤0.01%
23,500
– –
ACB
712
Aurora Cannabis
ACB
$185M
$114K ﹤0.01%
217
+25
+13% +$18.5K
GFI icon
713
Gold Fields
GFI
$36.5B
$110K ﹤0.01%
22,438
+1,316
+6% +$7.16K
FBIO icon
714
Fortress Biotech
FBIO
$88.7M
$32K ﹤0.01%
1,500
– –
AFG icon
715
American Financial Group
AFG
$12.1B
– –
-4,000
Closed -$408K
AGCO icon
716
AGCO
AGCO
$7.2B
– –
-6,000
Closed -$463K
AMRC icon
717
Ameresco
AMRC
$1.36B
– –
-16,513
Closed -$242K
ASH icon
718
Ashland
ASH
$3.5B
– –
-6,000
Closed -$478K
CVSA
719
Covista Inc
CVSA
$4.8B
– –
-8,000
Closed -$359K
AU icon
720
AngloGold Ashanti
AU
$48.7B
– –
-117,213
Closed -$2.08M
AUPH icon
721
Aurinia Pharmaceuticals
AUPH
$2.11B
– –
-130,000
Closed -$852K
AYI icon
722
Acuity Brands
AYI
$10.8B
– –
-1,930
Closed -$265K
BBVA icon
723
Banco Bilbao Vizcaya Argentaria
BBVA
$156B
– –
-445
Closed -$2.47M
BHP icon
724
BHP
BHP
$230B
– –
-71
Closed -$3.66M
BLDP
725
Ballard Power Systems
BLDP
$790M
– –
-11,000
Closed -$45K
27 28
29
30 31

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return
NAM
Nissay Asset Management Tokyo, Japan $18.9B AUM 27.21% 1-Year Est. Return

Candriam SCA's Q3 2019 Portfolio in Review

As of Q3 2019, Candriam SCA held 863 positions worth $7.55B, down 5.9% from $8.02B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Candriam SCA withdrew a net $301M in Q3 2019, closing 128 positions and reducing 256 holdings. Its most notable exit was Celgene Corp, an estimated $70.2M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, down from 33% a quarter earlier, followed by Technology and Financials.

Against the trend, Candriam SCA opened a new position in Nike worth $27.8M.

  • Candriam SCA's largest Q3 2019 buy was Nike: 295,763 shares worth $27.8M.
  • Candriam SCA added most to AbbVie in Q3 2019, an estimated $21.9M increase.
  • Candriam SCA's biggest Q3 2019 reduction was Biogen, cutting an estimated $43.3M.
  • Candriam SCA fully exited Celgene Corp in Q3 2019, selling an estimated $70.2M.
  • Candriam SCA's ten largest holdings make up 21% of its $7.55B portfolio in Q3 2019.
  • Candriam SCA opened 59 new positions and closed 128 in Q3 2019.
  • Candriam SCA's portfolio value fell 5.9% quarter-over-quarter to $7.55B.

Based on Candriam SCA's 13F filing for Q3 2019, filed 21 Oct 2019.